Not recruitingEUCTR 2021-000319-21

Treating Nightmares in PTSD with the α-adrenergic Agents Clonidine and Doxazosin: A Randomized-Controlled Feasibility Study (ClonDoTrial)

This historical record does not confirm current site availability.

Historical research recordGermany

The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Berlin, Germany · Giessen, Germany and 3 more locationsSee all locations and recruitment
Compensation: Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: Charité – Universitätsmedizin Berlin
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 2
Locations: Germany
Age range: Not clearly listed
Official registry ID: EUCTR 2021-000319-21
Official title: Show the full official title
Treating Nightmares in Posttraumatic Stress Disorder with the α-adrenergic Agents Clonidine and Doxazosin: A Randomized-Controlled Feasibility Study (ClonDoTrial)

Need help understanding this study?

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Recruitment & locations

Not recruiting

Berlin · Giessen · Hamburg

2 more locations

Mannheim
Tuebingen

Registry details

Original registry record

Current country statuses

Germany — Ended

Historical country statuses

Germany — Ongoing

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Charité – Universitätsmedizin Berlin.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me